- Home
- TRI vs ZTS Comparison
TRI vs ZTS Comparison
Compare TRI & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRI
- ZTS
- Stock Information
- Founded
- TRI 1851
- ZTS 1952
- Country
- TRI Canada
- ZTS United States
- Employees
- TRI N/A
- ZTS 14100
- Industry
- TRI
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- TRI
- ZTS Health Care
- Exchange
- TRI Nasdaq
- ZTS Nasdaq
- Market Cap
- TRI 75.7B
- ZTS 79.8B
- IPO Year
- TRI N/A
- ZTS 2013
- Fundamental
- Price
- TRI $161.16
- ZTS $176.99
- Analyst Decision
- TRI Buy
- ZTS Strong Buy
- Analyst Count
- TRI 8
- ZTS 8
- Target Price
- TRI $178.38
- ZTS $219.50
- AVG Volume (30 Days)
- TRI 309.2K
- ZTS 2.8M
- Earning Date
- TRI 11-05-2024
- ZTS 11-04-2024
- Dividend Yield
- TRI 1.34%
- ZTS 0.97%
- EPS Growth
- TRI 5.99
- ZTS 8.38
- EPS
- TRI 5.07
- ZTS 5.32
- Revenue
- TRI $7,164,000,000.00
- ZTS $9,152,000,000.00
- Revenue This Year
- TRI $8.18
- ZTS $9.19
- Revenue Next Year
- TRI $6.93
- ZTS $5.35
- P/E Ratio
- TRI $31.78
- ZTS $33.35
- Revenue Growth
- TRI 6.23
- ZTS 9.33
- 52 Week Low
- TRI $138.09
- ZTS $144.80
- 52 Week High
- TRI $176.03
- ZTS $201.92
- Technical
- Relative Strength Index (RSI)
- TRI 38.24
- ZTS 45.11
- Support Level
- TRI $159.00
- ZTS $173.24
- Resistance Level
- TRI $173.56
- ZTS $177.20
- Average True Range (ATR)
- TRI 2.89
- ZTS 4.19
- MACD
- TRI -0.62
- ZTS 0.58
- Stochastic Oscillator
- TRI 14.80
- ZTS 79.50
About TRI Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008. In 2021, Thomson Reuters completed the sale of Refinitiv to LSE Group. Thomson Reuters' three largest segments are its legal professionals, Tax and accounting, and corporates segments. Legal professionals is about 42% of the firm's revenue and 47% of the firm's adjusted EBITDA. Tax and accounting makes up about 20%-25% of the firm's revenue and EBITDA. Corporates, which consists of legal professionals and tax and accounting products sold to corporations, also makes up about 20%-25% of the firm's revenue and EBITDA. Thomson Reuters' smaller segments include its Reuters news business and global print business.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.